Journal of the American Academy of Child & Adolescent Psychiatry
Volume 49, Issue 4 , Pages 345-355 , April 2010

Beyond the Dual Pathway Model: Evidence for the Dissociation of Timing, Inhibitory, and Delay-Related Impairments in Attention-Deficit/Hyperactivity Disorder

  • Edmund Sonuga-Barke, Ph.D.

      Affiliations

    • University of Southampton
    • Ghent University
    • Corresponding Author InformationCorrespondence to: Dr. Sonuga-Barke, Institute for Disorder of Impulse and Attention, School of Psychology, University of Southampton, Highfield, Southampton, SO17 1BJ, UK
    • ,
  • Paraskevi Bitsakou, Ph.D.

      Affiliations

    • University of Southampton
    • ,
  • Margaret Thompson, M.D.

      Affiliations

    • University of Southampton

,Accepted 7 January 2010.

References 

  1. Nigg JT. Neuropsychologic theory and findings in attention-deficit/hyperactivity disorder: the state of the field and salient challenges for the coming decade. Biol Psychiatry. 2005;57:1424–1435
  2. Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry. 2005;57:1336–1346
  3. Bitsakou P, Psychogiou L, Thompson M, Sonuga-Barke E. Inhibitory Deficits in Attention Deficit Hyperactivity Disorder are Independent of Basic Processing Efficiency and IQ. J Neur Trans. 2008;115:261–268
  4. Rapport MD, Bolden J, Kofler MJ, Sarver DE, Raiker JS, Alderson RM. Hyperactivity in boys with attention-deficit/hyperactivity disorder (ADHD): a ubiquitous core symptom or manifestation of working memory deficits?. J Abnorm Child Psychol. 2009;37:521–534
  5. Banaschewski T, Ruppert S, Tannock R, et al. Colour perception in ADHD. J Child Psychol Psychiatry. 2006;47:568–572
  6. Coghill DR, Rhodes SM, Matthews K. The neuropsychological effects of chronic methylphenidate on drug-naïve boys with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007;62:954–962
  7. Toplak ME, Dockstader C Tannock R. Temporal information processing in ADHD: findings to date and new methods. J Neurosci Methods. 2006;151:15–29
  8. Luman M, Oosterlaan J, Sergeant JA. The impact of reinforcement contingencies on AD/HD: a review and theoretical appraisal. Clin Psychol Rev. 2005;25:183–213
  9. Sergeant JA, Willcutt E, Nigg J. How clinically functional are executive function measures of ADHD?. In:  Shaffer D,  Leibenluft E,  Rohde LA,  Sirovatka P,  Regier DA editor. Externalizing Disorders of Childhood: Refining the Research Agenda for DSM-V. Arlington, VA: American Psychiatric Association; 2007;
  10. Nigg JT, Willcutt EG, Doyle AE, Sonuga-Barke EJS. Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes?. Biol Psychiatry. 2005;57:1224–1230
  11. Sonuga-Barke EJ, Sergeant J, Nigg J, Willcutt E. Executive dysfunction and delay aversion in ADHD: nosological and diagnostic implications. Child Adolesc Psychiatr Clin North Am. 2008;17:367–384
  12. Sonuga-Barke EJ. Psychological heterogeneity in AD/HD—a dual pathway model of behaviour and cognition. Behav Brain Res. 2002;130:29–36
  13. Sonuga-Barke EJ. The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics. Neurosci Biobehav Rev. 2003;27:593–604
  14. Sonuga-Barke EJ. Causal models of attention-deficit/hyperactiviy disorder: from common simple deficits to multiple developmental pathways. Biol Psychiatry. 2005;57:1231–1238
  15. Marco R, Miranda A, Schlotz W, et al. Delay and choice in ADHD: a test of the delay aversion hypothesis. Neuropsychology. 2009;23:367–380
  16. Solanto MV, Abikoff H, Sonuga-Barke E, et al. The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: a supplement to the NIMH multimodal treatment study of AD/HD. J Abnorm Child Psychol. 2001;29:215–228
  17. Sonuga-Barke EJ, De Houwer J, De Ruiter K, Ajzenstzen M, Holland S. AD/HD and the capture of attention by briefly exposed delay-related cues: evidence from a conditioning paradigm. J Chid Psychol Psychiatry. 2003;44:1–11
  18. Thorell LB. Do delay aversion and executive function deficits make distinct contributions to the functional impact of ADHD symptoms? (A study of early academic skill deficits). J Child Psychol Psychiatry. 2007;14:1061–1070
  19. Campbell SB, von Stauffenberg C. Delay and inhibition as early predictors of ADHD symptoms in third grade. J Abnorm Child Psychol. 2009;37:1–15
  20. Van den Bergh FS, Bloemarts E, Groenink L, Olivier B, Oosting RS. Delay aversion: effects of 7-OH-DPAT, 5-HT1A/B-receptor stimulation and D-cycloserine. Pharmacol Biochem Behav. 2006;85:736–743
  21. Wåhlstedt C, Thorell LB, Bohlin G. Heterogeneity in ADHD: neuropsycholgical pathways, comorbidity and symptom domain. J Abnorm Child Psychol. 2009;37:551–564
  22. Koch G, Brusal L, Carrillo F, et al. Cerebellar magnetic stimulation decreases-inducd dyskinesias in Parkinson disease. Neurology. 2009;73:113–119
  23. Shih LY, Kuo WJ, Yeh TC, Tzeng OJ, Hsieh JC. Common neural mechanisms for explicit timing in the sub-second range. Neuroreport. 2009;20:897–901
  24. Neufang S, Fink GR, Herpetz-Dahlmann B, Willmes K, Konrad K. Developmental changes in neural activation and psychphysiological interaction patterns of brain regions associated with interference control and time perception. Neuroimage. 2008;43:399–409
  25. Toplak ME, Rucklidge JJ, Hetherington R, John SCF, Tannock R. Time perception deficits in attention-deficit/hyperactivity disorder and comorbid reading difficulties in child and adolescent samples. J Child Psychol Psychiatry. 2003;44:888–903
  26. Barkley RA, Koplowitz S, Anderson T, McMurray MB. Sense of time in children with ADHD: effects of duration, distraction, and stimulant medication. J Internat Neuropsychol Soc. 1997;3:359–369
  27. Barkley RA, Murphy KR, Bush T. Time perception and reproduction in young adults with attention deficit hyperactivity disorder. Neuropsychology. 2001;15:351–360
  28. Rommelse NNJ, Oosterlaan J, Buitelaar J, Faraone SV, Sergeant JA. Time reproduction in children with ADHD and their nonaffected siblings. J Am Child Adolesc Psychiatry. 2007;46:582–590
  29. Rubia K, Noorloos J, Smith A, Gunning B, Sergeant J. Motor timing deficits in community and clinical boys with hyperactivity behavior: the effect of methylphenidate on motor timing. J Abn Child Psychol. 2003;31:301–313
  30. Smith A, Taylor E, Rogers JW, Newman S, Rubia K. Evidence for a pure time perception deficit in children with ADHD. J Child Psychol Psychiatry. 2002;43:529–542
  31. Yang B, Chan RCK, Zou X, et al. Time perception deficit in children with ADHD. Brain Res. 2009;1170:90–96
  32. Ben-Pazi H, Gross-Tsur V, Bergman H, Shalev RS. Abnormal rhythmic motor response in children with attention-deficit-hyperactivity disorder. Dev Med Child Neurol. 2003;45:743–745
  33. Rommelse NNJ, Altink ME, Oosterlaan J, et al. Speed, variability, and timing on motor output in ADHD: which measures are useful for endophenotypic research?. Behav Gen. 2008;38:121–132
  34. Rubia K, Taylor A, Taylor E, Sergeant J. Synchronization, anticipation, and consistency in motor timing of children with dimensionally defined attention deficit hyperactivity behavior. Percept Mot Skills. 1999;89:1237–1258
  35. Rubia K, Halari R, Christakou A, Taylor E. Impulsiveness as a timing disturbance: neurocognitive abnormalities in attention-deficit hyperactivity disorder during temporal processes and normaliztion iwht methylphenidate. Phil Trans R Soc Lond B Biol Sci. 2009;364:1919–1931
  36. Coghill D, Nigg J, Rothenberger A, Sonuga-Barke EJ, Tannock R. Whither causal models in the neuroscience of ADHD?. Dev Sci. 2005;8:105–114
  37. Swanson JM, Kinsbourne M, Nigg J, et al. Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol Rev. 2007;17:39–59
  38. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003;160:636–645
  39. Waldman ID. Statistical approaches to complex phenotypes: evaluating neuropsychological endophenotypes for attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57:1347–1356
  40. Schachar RJ, Crosbie J, Barr CL, et al. Inhibition of motor responses in siblings concordant and discordant for attention deficit hyperactivity disorder. Am J Psychiatry. 2005;162:1076–1082
  41. Rommelse NNJ, Altink ME, Oosterlaan J, Buschgens CJM, Buitelaar J, Sergeant JA. Support for an independent familial segregation of executive and intelligence endophenotypes in ADHD families. Psychol Med. 2008;38:1595–1606
  42. Himpel S, Banaschewski T, Gruttner A, et al. Duration discrimination in the range of milliseconds and seconds in children with ADHD and their unaffected siblings. Psychol Med. 2009;6:1–7
  43. Slaats-Willemse D, de Sonneville L, Swaab-Barneveld H, Buitelaar J. Motor flexibility problems as a marker for genetic susceptibility to ADHD. Biol Psychiatry. 2005;58:233–238
  44. Bitsakou P, Psychogiou L, Thompson M, Sonuga-Barke E. Delay aversion in attention deficit/hyperactivity disorder (ADHD): an empirical investigation of the broader phenotype. Neuropsychologia. 2009;47:446–456
  45. Toplak ME, Tannock R. Tapping and anticipation performance in attention deficit hyperactivity disorder. Percept Mot Skills. 2005;100:659–675
  46. Carelli MG, Forman H, Mantyla T. Sense of time and executive functioning in children and adults. Child Neuropsychol. 2008;14:372–386
  47. Barkley RA. Behavioural inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull. 1997;121:65–94
  48. Engelhardt PE, Nigg JT, Carr LA, Ferreira F. Cognitive inhibition and working memory in attention-deficit hyperactivity disorder. J Abnorm Psychol. 2008;117:591–605
  49. Kasselimis DS, Margarity M, Vlachos F. Cerebellar function, dyslexia and articulation speed. Child Neuropsychol. 2008;14:303–313
  50. Ramus F, Pidgeon E, Frith U. The relationship between motor control and phonology in dyslexic children. J Child Psychol Psychiatry. 2003;44:712–722
  51. Brookes K, Xu X, Chen W, et al. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry. 2006;11:934–953
  52. Taylor E, Sandberg G, Thorley G, Giles S. The epidemiology of childhood hyperactivity. Maudsley Monograph No. 33 Oxford: Oxford University Press; 1991;
  53. Goodman R. The Strengths and Difficulties Questionnaire: a research note. J Child Psychol Psychiatry. 1997;38:581–586
  54. Logan GD, Schachar RJ, Tannock R. Impulsivity and inhibitory control. Psychol Sci. 1997;8:60–64
  55. Hogan AM, Vergha-Khadem F, Kirkham FJ, Baldeweg T. Maturation of action monitoring from adolescents to adulthood: an ERP study. Dev Sci. 2005;8:525–534
  56. Kuntsi J, Oosterlaan J, Stevenson J. Psychological mechanisms in hyperactivity: I. Response inhibition deficit, working memory impairment, delay aversion, or something else?. J Child Psychol Psychiatry. 2001;42:199–210
  57. Bitsakou P, Antrop I, Wiersema JR, Sonuga-Barke EJS. Probing the limits of delay intolerance: preliminary young adult data from the Delay Frustration Task (DeFT). J Neurosci Methods. 2006;151:38–44
  58. Sonuga-Barke EJ, Taylor E. The effect of delay on hyperactive and non-hyperactive children's response times: a research note. J Child Psychol Psychiatry. 1992;33:1091–1096
  59. Wetherill GB, Levitt H. Sequential estimation of points on a psychological function. Br J Math Stat Psychol. 1965;18:1–10
  60. Wechsler D. Wechsler Intelligence Scale for Children. (3rd ed.). San Antonio, TX: Psychological Corporation; 1991;
  61. Torgesen JK, Wagner RK, Rashotte CA. Test of word reading efficacy (TOWRE). Austin, TX: Pro-ed; 1999;
  62. Sattler JM. Assessment of children: WISC-III and WPPSI-R Supplement. San Diego, CA: J. M. Sattler; 1992;
  63. Bidwell LC, Willcutt EG, DeFries JC, Pennington BF. Testing for neuropsychological endophenotypes in siblings discordant for attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007;62:991–998
  64. Nigg JT, Blaskey L, Stawicki J, Sachek J. Evaluating the endophenotype model of ADHD neuropsychological deficit: results for parents and siblings of children with DSM-IV ADHD combined and inattentive subtypes. J Abnorm Psychol. 2004;113:614–625
  65. Slaats-Willemse D, Swaab-Barneveld H, de Sonneville L, van der Meulen E, Buitelaar J. Deficient response inhibition as a cognitive endophenotype of ADHD. J Am Acad Child Adolesc Psychiatry. 2003;42:1242–1248
  66. Waldman ID, Nigg JT, Gizer IR, Park L, Rappley MD, Friderici K. The adrenergic receptor α-2A gene (ADRA2A) and neuropsychological executive functions as putative endophenotypes for childhood ADHD. Cogn Aff Behav Neurosci. 2006;6:18–30
  67. Doyle AE, Biederman J, Seidman LJ, Reske-Nielsen JJ, Faraone S. Neuropsychological functioning in relatives of girls with and without ADHD. Psychol Med. 2005;35:1121–1132
  68. Andreou P, Neale BM, Chen W, Christiansen H, Gabriels I, Heise A, et al. Reaction time performance in ADHD: improvement under fast-incentive condition and familial effects. Psychol Med. 2007;31:1–13
  69. Kuntsi J, Rogers H, Swinard G, Rörger N, van der Meere J, Rijsdijk F, et al. Reaction time, inhibition, working memory and ‘delay aversion' performance: genetic influences and their interpretation. Psychol Med. 2006;36:613–1624
  70. Sonuga-Barke EJS, Wiersema JR, van der Meere JJ, Roeyers H. Context dependent dynamic models of attention deficit/hyperactivity disorder: differentiating common and unique elements of the state regulation deficit and delay aversion models. Neuropsychol Rev. 2009;In press
  71. Markomichali P, Donnelly N, Sonuga-Barke E. Cognitive training for attention, inhibition and working memory deficits: a potential treatment for ADHD?. Advanc ADHD. 2009;3:89–96

 This research was funded in part by ESRC CASE Award PTA-033-2003-00046 with Eli Lilley Ltd (to E.S.-B. and M.T. for P.B.).

 Clinical data from the participants included in this paper contributed to the IMAGE project (Faraone; National Institutes of Health grant R01 MH62873-01A1).

 Disclosure: Dr. Sonuga-Barke has served on the speakers' bureau and as a consultant for Shire and UCB Pharma. He has received research support from Janssen Cilag, Shire, Qbtech, and Flynn Pharma. He has served on the advisory board for Shire, Flynn Pharma, UCB Pharma, and Astra Zeneca. He has received conference support from Shire. Dr. Thompson has received education sponsorship from Eli Lilly and Janssen Cilag. She has received unrestricted research grants from Eli Lilly, Janssen Cilag, UCB Pharma, and Shire. She has served on the advisory board for Eli Lilly, UCB Pharma, and Shire. She has received drug trial support from Eli Lilly and Janssen Cilag. She has received lecture fees from Eli Lilly and Janssen Cilag. She has received funding for the support of Ph.D. students from Eli Lilly and Janssen Cilag. Dr. Bitsakou reports no biomedical financial interests or potential conflicts of interest.

PII: S0890-8567(10)00074-2

doi: 10.1016/j.jaac.2009.12.018

Journal of the American Academy of Child & Adolescent Psychiatry
Volume 49, Issue 4 , Pages 345-355 , April 2010

Article Tools

* Image Usage & Resolution